Battle

New York Attorney General Takes Stand Against Texas in Legal Battle Over Abortion Pills

by

New York’s Attorney General Letitia James is set to challenge Texas over a law that limits access to abortion medications. This initiative marks a significant confrontation in the ongoing national debate surrounding reproductive rights, as Texas seeks to impose restrictions that could affect residents across state lines. The legal maneuvering comes in response to a recent Texas law designed to tighten regulations on abortion pills, which has raised alarms about its potential ripple effects in other states. James argues that such laws infringe upon the rights of individuals seeking medications that have been deemed safe … Read more

Venom’s Visionaries: Founders Mantas and Abaddon Launch Fan-Funded Legal Battle Against Cronos

by

San Francisco, California — The founders of Venom, Mantas and Abaddon, have launched a fan-funded lawsuit against Cronos, a decision that has sparked discussions within the music community. This move comes as the duo, known for their work in the heavy metal scene, seeks to address grievances they claim have been ignored. The legal action was initiated after these artists alleged that Cronos, the frontman of the iconic band Venom, infringed on their rights and mismanaged their contributions to the band. Mantas and Abaddon are relying on their fan base to financially support this endeavor, … Read more

Patent Battle Erupts in Europe: ToolGen Sues Lonza Over CRISPR Technology Infringement Amidst Gene Therapy Breakthroughs

by

SEOUL, South Korea — ToolGen, a prominent player in genome editing, has initiated legal proceedings against Dutch manufacturer Lonza Netherlands B.V. The lawsuit, filed in The Hague, alleges that Lonza infringes on ToolGen’s patent rights while producing CASGEVY, the first authorized CRISPR-based gene therapy for treating sickle cell disease and beta-thalassemia. According to the claims, Lonza’s production processes at its Dutch facility violate ToolGen’s European patent (EP 4 357 457), which is centered on the CRISPR-Cas9 RNP technology. CASGEVY, developed collaboratively by Vertex Pharmaceuticals and CRISPR Therapeutics, has gained regulatory approval in multiple regions, including … Read more